Michael Forbes

Candian marijuana operator Adastra Holdings Ltd. (OTC: XTXXF)(CSE:XTRX)(FRA:D2EP) reported Thursday financial results for the three months ended June 30, 2023, disclosing net revenue of CA$7.1 million, up by 132.68% year-over-year. The company attributes revenue improvement to a significant...

Cannabis producer Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTC: XTXXF) reported on Tuesday financial results for the three months ended March 31, 2023. During the first quarter of 2023, the Langley, British Columbia-based cannabis concentrates manufacturer garnered CA$ 9.5 million ($6.98...

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) FY 2022 net revenue increased 136% to CA$13.3 million ($9.8 million), compared to CA$5.6 million in FY 2021. FY 2022 Financial Highlights Gross profit of CA$6.1 million, an increase of 214% compared CA$1.9 million in FY2021. Gross margin...

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) has been served with a civil claim filed in the Supreme Court of British Columbia pursuant to the Class Proceedings Act, R.S.B.C. 1996, c. 50 alleging that the company's press release of February 22, 2023 misstated certain material facts...

A Langley, British Columbia, cannabis company got the green light from Health Canada to produce and sell cocaine earlier this month, but the province's Premier says he was unaware of the move, reported CityNews Vancouver. B.C. Premier David Eby is now opposing the decision allowing...

Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTCPK: XTXXF) reported on Wednesday that Adastra Labs got the green light from Health Canada earlier this month for its amendment to include cocaine as a substance that the company can legally possess, produce, sell and distribute. The Langley,...

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space. TerrAscend Expands Leadership TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) tapped...

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP), released its financial results for the three and nine months ended September 30, 2022. Q3 2022 Financial Highlights Gross revenues of CA$3.8 million ($2.83 million) in Q3 2022, compared to CA$1.81 million in Q3 2021, and CA$3.05 million...

OnPoint Laboratories Names Samuel Richard CEO & Equity Partner OnPoint Laboratories has appointed Samuel Richard to serve as CEO and equity partner. Richard succeeds Jeff Cardot, founder and current CEO, as part of a planned transition. Cardot will continue to be involved with the day-to-day...

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021. 2021 Annual and Q4 Financial Highlights Net loss of $2.75 million in 2021 compared to net loss of $7.62...

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the following activities: Sell cannabis extracts to medical cannabis patients and licensed health...

Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE: XTRX) (FRA: D2EP) recently completed the submission of its application for a controlled drugs and substances dealer's license. What Does It Mean? Adastra has successfully taken the first steps to become a licensed tester, extractor and seller...

Adastra Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) entered into a private label manufacturing agreement with Zyre Brands Corp. under which Adastra will manufacture custom-formulated cured resin vape products to sell under the Zyre brand in the Canadian adult-use market. Adastra's ability to...